Altimmune
ALT
ALT
96 hedge funds and large institutions have $336M invested in Altimmune in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
+8
Holders Change %
+9.09%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
36
Reduced
20
Closed
16
Calls
$10.9M
Puts
$8.33M
Net Calls
+$2.59M
Net Calls Change
+$4.09M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$41.6M |
| 2 |
CCM
2
CAAS Capital Management
New York
|
$15.6M |
| 3 |
BBA
3
Baker Bros. Advisors
New York
|
$39M |
| 4 |
AC
4
Armistice Capital
New York
|
$7.57M |
| 5 |
5
Millennium Management
New York
|
$10.4M |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$1.3M |
| 2 |
VA
2
VR Adviser
New York
|
$49.5M |
| 3 |
EP
3
Eversept Partners
New York
|
$0 |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$5.83M |
| 5 |
CS
5
Credit Suisse
Zurich,
Switzerland
|
$12.9M |
